Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5

BMC Molecular Biology

Volumn 7, Issue , 2006, Pages

  Denise, Hubert ^a   Poot, Jacqueline ^b   Jiménez, Maribel ^a,c   Ambit, Audrey ^a   Herrmann, Daland C ^a,b,d   Vermeulen, Arno N ^b   Coombs, Graham H ^a   Mottram, Jeremy C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INTERVET INTERNATIONAL BV   (Netherlands)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PEPTIDASE; MUTANT PROTEIN; PEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONING; CONTROLLED STUDY; DATA ANALYSIS; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC MANIPULATION; GENOME; HAMSTER; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION; LEISHMANIA INFANTUM; LEISHMANIA MEXICANA; LIFE CYCLE; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PHENOTYPE; PROMASTIGOTE;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CRICETINAE; CYSTEINE ENDOPEPTIDASES; DOGS; GENE DELETION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOME, PROTOZOAN; HUMANS; LEISHMANIA INFANTUM; LEISHMANIA MEXICANA; LEISHMANIASIS, VISCERAL; MESOCRICETUS; MOLECULAR SEQUENCE DATA; MUTATION; PROTOZOAN PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; U937 CELLS;

CANIS FAMILIARIS; CRICETINAE; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM;

EID: 33845187107     PISSN: 14712199     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-7-42     Document Type: Article

References (51)

1. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Vélez R, Molina R, Moreno J: Leishmania and human immunodeficiency virus coinfection: The first 10 years. Clin Microbiol Rev 1997, 10:298-319.
2. Coler RN, Reed SG: Second-generation vaccines against leishmaniasis. Trends Parasitol 2005, 21:244-249.
3. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, Adlem E, Aert R, et al.: The genome of the kinetoplastid parasite, Leishmania major. Science 2005, 309:436-442.
4. Alvar J, Canavate C, Molina R, Moreno J, Nieto J: Canine leishmaniasis. Adv Parasitol 2004, 57:1-88.
5. Botilde Y, Laurent T, Quispe TW, Chicharro C, Canavate C, Cruz I, Kuhls K, Schonian G, Dujardin JC: Comparison of molecular markers for strain typing of Leishmania infantum. Infect Genet Evol 2006.
6. Dye C: The logic of visceral leishmaniasis control. Am J Trop Med Hyg 1996, 55:125-130.
7. El Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, Ghedin E, Worthey EA, Delcher AL, Blandin G, et al.: The genome sequence of Trypanosoma cruzi, etiologic agent of chagas disease. Science 2005, 309:409-415.
8. Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, Lennard NJ, Caler E, Hamlin NE, Haas B, et al.: The genome of the African trypanosome Trypanosoma brucei. Science 2005, 309:416-422.
9. Kissinger JC: A tale of three genomes: the kinetoplastids have arrived. Trends Parasitol 2006.
10. Stober CB, Lange UG, Roberts MT, Gilmartin B, Francis R, Almeida R, Peacock CS, McCann S, Blackwell JM: From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection. Vaccine 2006, 24:2602-2616.
11. Zhang WW, Mendez S, Ghosh A, Myler P, Ivens A, Clos J, Sacks DL, Matlashewski G: Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem 2003, 278:35508-35515.
12. Campbell M, Diao H, Ji JX, Soong L: DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous leishmaniasis. Infect Immun 2003, 71:6270-6278.
13. Melby PC, Yang J, Zhao WG, Perez LE, Cheng J: Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Infect Immun 2001, 69:4719-4725.
14. Mottram JC, Coombs GH, Alexander J: Cysteine peptidases as virulence factors of Leishmania. Curr Opin Microbiol 2004, 7:375-381.
15. Pollock KG, McNeil KS, Mottram JC, Lyons RE, Brewer JM, Coombs GH, Alexander J: The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J Immunol 2003, 170:1746-1753.
16. Alexander J, Coombs GH, Mottram JC: Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a T Helper I (THI) response. J Immunol 1998, 161:6794-6801.
17. da Costa Pinheiro PH, Souza Dias S, Eulalio KD, Mendonca IL, Katz S, Barbieri CL: Recombinant Cysteine Proteinase from Leishmania (Leishmania) chagasi Implicated in Human and Dog T-Cell Responses. Infect Immun 2005, 73:3787-3789.
18. Rafati S, Salmanian AH, Taheri T, Vafa M, Fasel N: A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major. Vaccine 2001, 19:3369-3375.
19. Bart G, Coombs GH, Mottram JC: Isolation of Imcpc, a gene encoding a Leishmania mexicana cathepsin B-like cysteine proteinase. Mol Biochem Parasitol 1995, 73:271-274.
20. Souza AE, Waugh S, Coombs GH, Mottram JC: Characterization of a multicopy gene for a major stage-specific cysteine proteinase of Leishmania mexicana. FEBS Lett 1992, 311:124-127.
21. Mottram JC, Robertson CD, Coombs GH, Barry JD: A develop-mentally regulated cysteine proteinase gene of Leishmania mexicana. Mol Microbiol 1992, 6:1925-1932.
22. Mottram JC, Souza AE, Hutchison JE, Carter R, Frame MJ, Coombs GH: Evidence from disruption of the Imcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc Natl Acad Sci USA 1996, 93:6008-6013.
23. Rioux JA, Lanotte G, Serres E, Pratlong F, Bastien P, Perieres J: Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp 1990, 65:111-125.
24. Sereno D, Lemesre JL: Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chem 1997, 41:972-976.
25. Beverley SM: Protozomics: trypanosomatid parasite genetics comes of age. Nat Rev Genet 2003, 4:11-19.
26. Omara-Opyene AL, Gedamu L: Molecular cloning, characterization and overexpression of two distinct cysteine protease cDNAs from Leishmania donovani chagasi. Mol Biochem Parasitol 1997, 90:247-267.
27. Mottram JC, North MJ, Barry JD, Coombs GH: A cysteineproteinase cDNA from Tryponosoma brucei predicts an enzyme with an unusual C-terminal extension. FEBS Lett 1989, 258:211-215.
28. Kuhls K, Mauricio IL, Pratlong F, Presber W, Schonian G: Analysis of ribosomal DNA internal transcribed spacer sequences of the Leishmania donovani complex. Microbes Infect 2005, 7:1224-1234.
29. Ochsenreither S, Kuhls K, Schaar M, Presber W, Schonian G: Multilocus microsatellite typing as a new tool for discrimination of Leishmania infantum MON-I strains. J Clin Microbiol 2006, 44:495-503.
30. Cascio A, Gradoni L, Scarlata F, Gramiccia M, Giordano S, Russo R, Scalone A, Camma C, Titone L: Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy. Am J Trop Med Hyg 1997, 57:75-78.
31. Dereure J, Rioux JA, Khiami A, Pratlong F, Perieres J, Martini A: [Ecoepidemiology of leishmaniases in Syria. 2-Presence, indogs, of Leishmania infantum Nicolle and Leishmania tropica (Wright) (Kinetoplastida-Trypanonomatidae)]. Ann Parasitol Hum Comp 1991, 66:252-255.
32. Harrat Z, Pratlong F, Belazzoug S, Dereure J, Deniau M, Rioux JA, Belkaid M, Dedet JP: Leishmania infantum and L. major in Algeria. Trans R Soc Trop Med Hyg 1996, 90:625-629.
33. Pratlong F, Rioux JA, Marty P, Faraut-Gambarelli F, Dereure J, Lanotte G, Dedet JP: Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features. J Clin Microbiol 2004, 42:4077-4082.
34. Jimenez M, Ferrer-Dufol M, Canavate C, Gutierrez-Solar B, Molina R, Laguna F, Lopez-Velez R, Cercenado E, Dauden E, Blazquez J: Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain. FEMS Microbiol Lett 1995, 131:197-204.
35. Chicharro C, Jimenez MI, Alvar J: Iso-enzymatic variability of Leishmania infantum in Spain. Ann Trop Med Parasitol 2003, 97(Suppl 1):57-64.
36. Poot J, Spreeuwenberg K, Sanderson SJ, Schijns VECJ, Mottram JC, Coombs GH, Vermeulen AN: Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protectdogs from infection with Leishmania infantum. Vaccine 2006, 24:2460-2468.
37. Poot J, Rogers ME, Bates PA, Vermeulen A: Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs. Vet Parasitol 2005, 130:41-53.
38. Anderson JM, Oliveira F, Kamhawi S, Mans BJ, Reynoso D, Seitz AE, Lawyer P, Garfield M, Pham M, Valenzuela JG: Comparative salivary gland transcriptomics of sandfly vectors of visceral leishmaniasis. BMC Genomics 2006, 7:52.
39. Frame MJ, Mottram JC, Coombs GH: Analysis of the roles of cysteine proteinases of Leishmania mexicana in the host-parasite interaction. Parasitology 2000, 121:367-377.
40. Zhang WW, Mendez S, Ghosh A, Myler P, Ivens A, Clos J, Sacks DL, Matlashewski G: Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem 2003, 278:35508-35515.
41. Gueiros-Filho FJ, Beverley SM: Selection against the dihydrofolate reductase-thymidylate synthase (DHFR-TS) locusas a probe of genetic alterations in Leishmania major. Mol Cell Biol 1996, 16:5655-5663.
42. Mottram JC, Souza AE, Hutchison JE, Carter R, Frame MJ, Coombs GH: Evidence from disruption of the Imcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc Natl Acad Sci USA 1996, 93:6008-6013.
43. Brooks DR, Denise H, Westrop GD, Coombs GH, Mottram JC: The stage-regulated expression of Leishmania mexicana CPB cysteine proteases is mediated by an intercistronic sequence element. J Biol Chem 2001, 276:47061-47069.
44. Beetham JK, Myung KS, McCoy JJ, Wilson ME, Donelson JE: Glycoprotein 46 mRNA abundance is post-transcriptionally regulated during development of Leishmania chagasi promastigotes to an infectious form. J Biol Chem 1997, 272:17360-17366.
45. Mundodi V, Kucknoor AS, Gedamu L: Role of Leishmania (Leishmania) chagasi amastigote cysteine protease in intracellular parasite survival: studies by gene disruption and antisense mRNA inhibition. BMC Mol Biol 2005, 6:3.
46. Souza AE, Bates PA, Coombs GH, Mottram JC: Null mutantsfor the Imcpa cysteine proteinase gene in Leishmania mexicana. Mol Biochem Parasitol 1994, 63:213-220.
47. Kiderlen AF, Kaye PM: A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites. J Immunol Methods 1990, 127:11-18.
48. Buffet PA, Sulahian A, Garin YJ, Nassar N, Derouin F: Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 1995, 39:2167-2168.
49. Bart G, Frame MJ, Carter R, Coombs GH, Mottram JC: Cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana. Mol Biochem Parasitol 1997, 88:53-61.
50. Denise H, Coombs GH, Mottram JC: Generation of Leishmania mutants lacking antibiotic resistance genes using a versatile hit-and-run targeting strategy. FEMS Microbiol Lett 2004, 235:89-94.
51. [http://www.genedb.org/].